New Video Commentary on Antitrust Campaign Against Drug Patent Settlements

Commentator Kurt Karst is a partner with Hyman, Phelps & McNamara and blogs on pharmaceutical law and policy issues at the firm’s FDA Law Blog.  His most recent post is on this subject, Patent Settlement Agreements: The Next Barrage.

Past Legal Pulse posts on “reverse payment” patent settlements include:

• Reverse Payment Settlement Agreements Likely Headed for Supreme Court Showdown
• Another Court Loss for FTC on “Reverse Payment” Drug Patent Settlements